Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2012
11/15/2012US20120288941 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
11/15/2012US20120288573 Use of extracts from salonum glaucophyllum for treating bone metabolism disorders and kidney disorders
11/15/2012US20120288565 Tamper-resistant oral opioid agonist formulations
11/15/2012US20120288564 Interpenetrating polymer network comprising fibrin
11/15/2012US20120288557 Acoustically sensitive drug delivery particles comprising low concentrations of phosphatidylethanolamine
11/15/2012US20120288539 Pharmaceutical composition comprising oligopeptides
11/15/2012US20120288537 Active self-healing biomaterial system
11/15/2012US20120288530 Tissue sealants from plasma derived proteins
11/15/2012US20120288526 Dna sequence and preparation of grass pollen allergen phl p4 by recombinant methods
11/15/2012US20120288514 Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides
11/15/2012US20120288513 Means for the inhibition of anti-beta1-adrenergic receptor antibodies
11/15/2012US20120288511 Glucagon/glp-1 receptor co-agonists
11/15/2012US20120288509 Analysis of methylated nucleic acid
11/15/2012US20120288505 Gene delivery
11/15/2012US20120288504 Antagonists of il-6 to prevent or treat thrombosis
11/15/2012US20120288492 NOVEL PYRIMIDINE COMPOUNDS AS mTOR AND PI3K INHIBITORS
11/15/2012US20120288491 Pharmaceutical compositions of active agents and cationic dextran polymer derivatives
11/15/2012US20120288489 Intranasal delivery of therapeutic enzymes to the central nervous system for the treatment of lysosomal storage diseases
11/15/2012US20120288487 Biodegradable paox polymer particle with cationic property
11/15/2012US20120288485 Use of jasmone for modulating melatonin production and calcification of the pineal gland
11/15/2012US20120288477 Type of consensus interferon and preparation method thereof
11/15/2012US20120288476 Structure and use of 5' phosphate oligonucleotides
11/15/2012US20120288475 Methods and use of growth hormone supergene family protein analogs for treatment of radiation exposure
11/15/2012US20120288474 Composition for treatment of cxcl8-mediated lung inflammation
11/15/2012US20120288473 Compositions, methods, and kits for eliciting an immune response
11/15/2012US20120288472 Regulation of t cell-mediated immunity by tryptophan
11/15/2012US20120288447 Peptide which passes through blood-brain barrier and targets apoptosis of neurodegenerative brain disease site and uses thereof
11/15/2012CA2835664A1 Wound debridement compositions containing seaprose and methods of wound treatment using same
11/15/2012CA2835627A1 Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof
11/15/2012CA2835624A1 Treatments for gastrointestinal disorders
11/15/2012CA2835214A1 Integrin receptor antagonists and their methods of use
11/15/2012CA2833554A1 Methods for preventing toxic drug-drug interactions in combination therapies comprising anti-erbb3 agents
11/14/2012EP2522723A1 Custom-made meganuclease and use thereof
11/14/2012EP2522721A2 Modified lecithin-cholesterol acyltransferase enzymes
11/14/2012EP2522677A1 Platelet glycoprotein IB alpha variant fusion polypeptides and methods of use thereof
11/14/2012EP2522676A2 Disintegrin variants and pharmaceutical uses thereof
11/14/2012EP2522359A1 Compounds with thioredoxin-like fold domain for the treatment of degenerative disorders
11/14/2012EP2522358A1 Peptides against rotavirus infection
11/14/2012EP2522354A1 Methods to reduce adverse events caused by pharmaceutical preparations comprising plasma derived proteins
11/14/2012EP2522351A1 Methods for treatment and prevention of tauopathies and amyloid beta amyloidosis by modulating CRF receptor signaling
11/14/2012EP2521732A2 Serine hydrolase formulation
11/14/2012EP2521566A2 Fibrinogen preparations enriched in fibrinogen with an extended alpha chain
11/14/2012EP2521565A1 Biomatrices to attract and retain regenerative and reparative cells
11/14/2012EP2521564A1 Apoe peptide dimers and uses thereof
11/14/2012EP2521563A2 Methods and compositions for providing protective immunity in the elderly
11/14/2012EP2521562A1 Ev576 for use in the treatment of viral infections of the respiratory tract
11/14/2012EP2521561A2 Linaclotide for the treatment of chronic constipation
11/14/2012EP2521538A1 Dry powder fibrin sealant
11/14/2012EP2521532A2 Method of use of stabilized plant-derived growth factor in skin care
11/14/2012CN1984669B Prion-specific peptide reagents
11/14/2012CN1927389B Application of human interferon containing pharmaceutical composition in preparation of medicine for preventing and treating virus infection of respiratory tract
11/14/2012CN1717417B Novel immunoadhesins for treating and prventing toxicity and pathogen-mediated diseases
11/14/2012CN1668721B Immunoadhesin comprising a glycoprotein VI domain
11/14/2012CN1434795B Acyl pseudodipeptides which carry a functionalised auxiliary arm
11/14/2012CN102781960A HSA-related compositions and methods of use
11/14/2012CN102781953A Oligopeptidic compounds and uses thereof
11/14/2012CN102781518A ACTRIIB antagonists and dosing and uses thereof
11/14/2012CN102781476A Methods for improving oral delivery
11/14/2012CN102781464A Biomatrices to attract and retain regenerative and reparative cells
11/14/2012CN102781463A Methods and compositions for skin regeneration
11/14/2012CN102781462A Novel nucleoside phosphonates and analogs
11/14/2012CN102781461A Topical acyl glutathione formulations
11/14/2012CN102781460A Agent for preventing muscular atrophy
11/14/2012CN102781459A Purified bowman-birk protease inhibitor proteins isolated from a soy processing stream
11/14/2012CN102781458A Polypeptide conjugate
11/14/2012CN102781427A Easy-disintegrating polymeric micelle composition
11/14/2012CN102776264A TNF-alpha short peptide related to apoptosis or necrosis and application thereof
11/14/2012CN102776222A Preparation and application of fused oral interferon for fowl
11/14/2012CN102775502A Alpha-interferon fusion protein
11/14/2012CN102775500A Chimeric antigen receptor iRGD-scFv (G250)-CD8-CD28-CD137-CD3zeta and application thereof
11/14/2012CN102775495A Polypeptide mixture, T cell vaccine and application thereof
11/14/2012CN102775492A High-activity human parathyroid hormone (1-34) mutant protein and activity detecting method thereof
11/14/2012CN102775491A Preparation method and application of single-chain human apoptosis-2 ligand (Apo2L) trimer protein
11/14/2012CN102775490A Secretory protein with migration activity and application thereof
11/14/2012CN102775474A Polypeptide and applications thereof
11/14/2012CN102772790A Compound echinacea purpurea preparation and preparation method and application thereof
11/14/2012CN102772789A Pharmaceutical application of PEG-modified recombinant humanized catalase
11/14/2012CN102772788A A pharmaceutical formulation comprising crystalline insulin and dissolved insulin
11/14/2012CN102772787A Stable formulations of insulinoptropic peptides
11/14/2012CN102772786A Application of BMP2/7 slow release system in glioma treatment
11/14/2012CN102772785A Composite medicine and ointment for hemostasis and preparation methods of composite medicine and ointment
11/14/2012CN102772784A Application of naltrexone combined methionine enkephalin in preparing medicament for treating cancer
11/14/2012CN102772783A Application of serum thymus factor in preparation of protecting drugs of antineoplastic drugs, and tumour physical and chemical treatment drugs
11/14/2012CN102772782A Novel lung cancer molecular marker retinoic acid receptor response protein 2
11/14/2012CN102772588A Natural medicine health care food
11/14/2012CN102772423A Application of amygdalin for ischemia heart protection
11/14/2012CN102190732B PGBD-2 fusion defensin, and preparation method and application thereof
11/14/2012CN102060912B Amyloid protein oligomer conformation type epitope polypeptide and application thereof
11/14/2012CN101892237B Polynucleotide related to mitochondrial membrane potential decrease and coded polypeptide and application thereof
11/14/2012CN101886123B Application of vascular endothelial growth factor receptor-2 (VEGFR-2) in temporomandibular joint disturbance
11/14/2012CN101851627B Gene encoding protein of eriocheir sinensis cysteine protease inhibitor Escystatin and application
11/14/2012CN101842083B LH liquid formulations
11/14/2012CN101748179B Preparation method of feather protein peptide
11/14/2012CN101711858B Medicine for treating cancer
11/14/2012CN101636174B Method for producing a tumor vaccine
11/14/2012CN101496827B Application of pumpkin protein in preparing medicament for treating chronic myeloid leukemia
11/14/2012CN101445802B Novel porcine circovirus virus, vaccines and diagnosis agent
11/14/2012CN101314034B Recombined nattokinase oral preparation, preparation method and application thereof
11/14/2012CN101065138B Compounds that inhibit hsp90 protein-protein interactions with iap proteins
11/14/2012CN101056612B Cosmetic compositions containing nigrospora sphaerica extracts
1 ... 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 ... 3163